These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6894075)

  • 1. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
    Purtilo DT
    Arch Pathol Lab Med; 1981 Mar; 105(3):119-21. PubMed ID: 6894075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of the X-linked lymphoproliferative syndrome.
    Purtilo DT
    Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EB virus, immunodeficiency, bone marrow aplasia, malignant mononucleosis and sex-linked lymphoproliferative B syndrome (XLP)].
    Mathé G
    Biomed Pharmacother; 1983; 37(6):249-50. PubMed ID: 6608379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E; Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.
    Purtilo DT; Sakamoto K; Barnabei V; Seeley J; Bechtold T; Rogers G; Yetz J; Harada S
    Am J Med; 1982 Jul; 73(1):49-56. PubMed ID: 6283885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; DeFlorio D; Hutt LM; Bhawan J; Yang JP; Otto R; Edwards W
    N Engl J Med; 1977 Nov; 297(20):1077-80. PubMed ID: 198660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
    Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
    Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases.
    Pattengale PK; Taylor CR; Pegalow C
    Am J Pediatr Hematol Oncol; 1981; 3(1):35-42. PubMed ID: 6263125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
    Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
    Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked lymphoproliferative syndrome registry report.
    Hamilton JK; Paquin LA; Sullivan JL; Maurer HS; Cruzi FG; Provisor AJ; Steuber CP; Hawkins E; Yawn D; Cornet JA; Clausen K; Finkelstein GZ; Landing B; Grunnet M; Purtilo DT
    J Pediatr; 1980 Apr; 96(4):669-73. PubMed ID: 7188959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
    Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
    Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.